SLAM
CRL icon

Swiss Life Asset Management’s Charles River Laboratories CRL Stock Holding History

Swiss Life Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
3,497
+302
+9% +$53.8K ﹤0.01% 773
2026
Q1 		$551K Buy
3,195
+853
+36% +$158K ﹤0.01% 828
2025
Q4 		$467K Buy
2,342
+132
+6% +$23.9K ﹤0.01% 818
2025
Q3 		$346K Sell
2,210
-382
-15% -$60.7K ﹤0.01% 845
2025
Q2 		$393K Buy
2,592
+473
+22% +$63.1K ﹤0.01% 686
2025
Q1 		$319K Sell
2,119
-1,209
-36% -$203K ﹤0.01% 670
2024
Q4 		$613K Buy
3,328
+2,265
+213% +$436K ﹤0.01% 644
2024
Q3 		$209K Sell
1,063
-154
-13% -$32K ﹤0.01% 624
2024
Q2 		$251K Sell
1,217
-405
-25% -$91.8K ﹤0.01% 556
2024
Q1 		$439K Sell
1,622
-516
-24% -$123K 0.01% 452
2023
Q4 		$507K Buy
+2,138
New +$420K 0.01% 563
2023
Q3 		– Sell
-10,365
Closed -$2.18M – 624
2023
Q2 		$2.18M Hold
10,365
– – 0.03% 481
2023
Q1 		$2.09M Buy
10,365
+5,732
+124% +$1.3M 0.03% 485
2022
Q4 		$1.01M Sell
4,633
-1,370
-23% -$299K 0.02% 492
2022
Q3 		$1.18M Sell
6,003
-22
-0.4% -$4.75K 0.02% 474
2022
Q2 		$1.29M Sell
6,025
-2,193
-27% -$536K 0.02% 471
2022
Q1 		$2.33M Sell
8,218
-450
-5% -$139K 0.03% 401
2021
Q4 		$3.27M Sell
8,668
-3,305
-28% -$1.28M 0.04% 384
2021
Q3 		$4.94M Buy
11,973
+2,133
+22% +$886K 0.07% 292
2021
Q2 		$3.64M Buy
+9,840
New +$3.29M 0.04% 376

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Swiss Life Asset Management's CRL Position: Q2 2026 in Review

Swiss Life Asset Management increased its Charles River Laboratories (CRL) stake by 9.5% in Q2 2026, buying an estimated $53.8K and bringing the position to 3,497 shares worth $793K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Swiss Life Asset Management first reported a position in CRL in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.94M in Q3 2021. 367 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Swiss Life Asset Management held 3,497 shares of Charles River Laboratories worth $793K as of Q2 2026.
  • Swiss Life Asset Management bought 302 Charles River Laboratories shares in Q2 2026, an estimated $53.8K.
  • Charles River Laboratories made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #773 holding.
  • Swiss Life Asset Management first reported a position in Charles River Laboratories in Q2 2021 and has held it in 20 quarters since.
  • Swiss Life Asset Management's Charles River Laboratories position peaked at $4.94M in Q3 2021.
  • 367 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.